RA CAPITAL MANAGEMENT, L.P. - 18 Jul 2025 SCHEDULE 13G Report for Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM)

Filing Manager
RA CAPITAL MANAGEMENT, L.P.
Reporting Manager
RA Capital Management, L.P.
Security
Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share
Symbol
CTNM
Shares outstanding
21,434,343 shares
Disclosed Ownership
2,122,000 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
25 Jul 2025, 17:00:51 UTC
Date of event
18 Jul 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"RA CAPITAL MANAGEMENT, L.P. disclosed 9.9% ownership in Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM) on 18 Jul 2025."

Quick Takeaways

  • RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G for Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM).
  • Disclosed ownership: 9.9%.
  • Date of event: 18 Jul 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 25 Jul 2025, 17:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 9.9% 2,122,000 0 2,122,000 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory
Peter Kolchinsky 9.9% 2,122,000 0 2,122,000 /s/ Peter Kolchinsky Peter Kolchinsky
Rajeev Shah 9.9% 2,122,000 0 2,122,000 /s/ Rajeev Shah Rajeev Shah
RA Capital Healthcare Fund, L.P. 9.9% 2,122,000 0 2,122,000 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager

Sponsored